Видео ютуба по тегу Platinum-Based Chemotherapy

Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment
Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment
Dr. Tolaney Discusses Patient Selection for Platinum-Based Therapy in TNBC
Dr. Tolaney Discusses Patient Selection for Platinum-Based Therapy in TNBC
Understanding Chemotherapy
Understanding Chemotherapy
KEYNOTE-024 update: pembrolizumab vs platinum-based chemotherapy in NSCLC
KEYNOTE-024 update: pembrolizumab vs platinum-based chemotherapy in NSCLC
Dr Maluf on Pembrolizumab Plus Platinum-Based Chemotherapy in Advanced Penile Cancer
Dr Maluf on Pembrolizumab Plus Platinum-Based Chemotherapy in Advanced Penile Cancer
CIA risk associated with taxane/platinum-based chemotherapy in young breast cancer patients
CIA risk associated with taxane/platinum-based chemotherapy in young breast cancer patients
29 First Line Chemotherapy
29 First Line Chemotherapy
What Are Platinum Based Chemotherapy Drugs? - Oncology Support Network
What Are Platinum Based Chemotherapy Drugs? - Oncology Support Network
Nondriver NSCLC: Adding Pembrolizumab to Platinum-Based Chemotherapy
Nondriver NSCLC: Adding Pembrolizumab to Platinum-Based Chemotherapy
Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...
Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...
Sacituzumab Govitecan Versus Platinum-Based Chemotherapy for Second-Line mUC
Sacituzumab Govitecan Versus Platinum-Based Chemotherapy for Second-Line mUC
CUPISCO: therapy guided by genomic profiling vs platinum-based chemotherapy in patients with CUP
CUPISCO: therapy guided by genomic profiling vs platinum-based chemotherapy in patients with CUP
Sugemalimab Plus Platinum-based chemotherapy For Metastatic non-small-cell lung cancer
Sugemalimab Plus Platinum-based chemotherapy For Metastatic non-small-cell lung cancer
Advances in the Treatment Landscape of Ovarian Cancer Over Last 30 Years
Advances in the Treatment Landscape of Ovarian Cancer Over Last 30 Years
Ivy Elkins on Pembroluzumab in Combination with Platinum-Based Chemo in Recurrent EGFR/ALK+ NSCLC
Ivy Elkins on Pembroluzumab in Combination with Platinum-Based Chemo in Recurrent EGFR/ALK+ NSCLC
Negative results from trial of roniciclib compared to platinum-based chemotherapy for SCLC
Negative results from trial of roniciclib compared to platinum-based chemotherapy for SCLC
Platinum-Based Anti-Tumor Agents
Platinum-Based Anti-Tumor Agents
Does time from initiation of platinum-based chemotherapy to second-line ICIs affect outcomes in mUC?
Does time from initiation of platinum-based chemotherapy to second-line ICIs affect outcomes in mUC?
PARP Inhibitors in Platinum Sensitive & Platinum Resistant Ovarian Cancers
PARP Inhibitors in Platinum Sensitive & Platinum Resistant Ovarian Cancers
Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectab...
Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectab...
Cisplatin: What Can You Expect?
Cisplatin: What Can You Expect?
Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer
Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer
Dr. Tolaney on Platinum-Based Therapy in Neoadjuvant Setting of TNBC
Dr. Tolaney on Platinum-Based Therapy in Neoadjuvant Setting of TNBC
Mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2 mutated metastati...
Mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2 mutated metastati...
Platinum-Based Doublets As the Cornerstone of First Line Treatment
Platinum-Based Doublets As the Cornerstone of First Line Treatment